Search
Powered By HealthLine
Health Tools
 Arthritis Questions and Answers
 Arthritis Symptom Checker
 Arthritis Drug Information
 Preventing Arthritis
 Arthritis Treatment
Featured Conditions
 Osteoarthritis
 Chronic Pain
 Rheumatoid Arthritis
 Diet & Exercise
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
Drug DescriptionSide Effects & Drug InteractionsWarnings & PrecautionsAdditional Info
Clinical PharmacologyOverdosage & ContraindicationsIndications & DosagePatient Info

Lotensin

[Benazepril]

Dosage Adjustment in Renal Impairment

For patients with a creatinine clearance < 30 mL/ min/ 1.73 m 2 (serum creatinine > 3 mg/ dL), the recommended initial dose is 5 mg Lotensin once daily. Dosage may be titrated upward until blood pressure is controlled or to a maximum total daily dose of 40 mg (see WARNINGS).

HOW SUPPLIED

Text Continues Below



Lotensin is available in tablets of 5 mg, 10 mg, 20 mg, and 40 mg, packaged with a desiccant in bottles of 90 and 100 tablets. Lotensin is also supplied in blister packages (1 tablet/ blister), in Accu-Pak ® Unit Dose boxes containing 10 strips of 10 blisters each.

Each tablet is imprinted with LOTENSIN on one side and the tablet strength (" 5," "10," "20," or "40") on the other.
The National Drug Codes for the various packages are
Tablet Dose Color Bottle of 90 Bottle of 100 Accu-Pak ® of 100

5 mg light yellow NDC 0083-0059-90 NDC 0083-0059-30 NDC 0083-0059-32 10 mg dark yellow NDC 0083-0063-90 NDC 0083-0063-30 NDC 0083-0063-32
20 mg pink NDC 0083-0079-90 NDC 0083-0079-30 NDC 0083-0079-32 40 mg dark rose NDC 0083-0094-90 NDC 0083-0094-30 NDC 0083-0094-32

Storage: Do not store above 30° C (86° F). Protect from moisture.
Dispense in tight container (USP).
T2002-06 REV: JANUARY 2002 Printed in U. S. A. 89008505

Novartis Pharmaceuticals Corporation East Hanover, New Jersey 07936
©2002 Novartis

Page:  << Prev | 1 | 2







HealthScout is a part of HealthCentral
About Us   Our Blog   Contact Us   Privacy Policy   Terms of Use   Site Map  
Copyright © 2001-2013. The HealthCentralNetwork, Inc. All rights reserved.
Advertising Policy   Editorial Policy Advertise With Us   Anti-Spam Policy   PR Newswire